Portuguese veterinary laboratory Vetlima and the animal nutrition and health factory of Doxal Italia have signed a Know-How Transfer Agreement, by which Vetlima is entitled to use the Bi-Modal Protection (BMP) technology, for the local manufacturing of an innovative form of Doxal’s medicated premix Oxitetravet BMP (based on Oxytetracycline).
“ We are proud that another European Veterinary Laboratory has decided to use our original BMP technology,” said Mauro Veneroni, Doxal’s Chief Executive Officer. “Since several years, companies from various EU countries, like Germany, UK, France and Spain, have been adopting our novel technique, for their production of medicated premixes and feed additives.” Read more ...
“ We are proud that another European Veterinary Laboratory has decided to use our original BMP technology,” said Mauro Veneroni, Doxal’s Chief Executive Officer. “Since several years, companies from various EU countries, like Germany, UK, France and Spain, have been adopting our novel technique, for their production of medicated premixes and feed additives.” Read more ...
No comments:
Post a Comment